Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$825M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$813M |
| 3 |
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
|
+$802M |
| 4 |
iShares MSCI India ETF
INDA
|
+$743M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$704M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.37B |
| 2 |
Microsoft
MSFT
|
+$2.08B |
| 3 |
NVIDIA
NVDA
|
+$1.74B |
| 4 |
Amazon
AMZN
|
+$1.08B |
| 5 |
Netflix
NFLX
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.41% |
| 2 | Consumer Discretionary | 1.14% |
| 3 | Financials | 1.02% |
| 4 | Healthcare | 0.75% |
| 5 | Industrials | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNBR
8151
PUT
DELISTED
Sleep Number
SNBR
| $181K | ﹤0.01% |
11,300
-300
| -3% | -$3.89K |
|
8152
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.2B
| $181K | ﹤0.01% |
+17,147
| New | +$174K |
|
8153
Atea Pharmaceuticals
AVIR
$395M
| $180K | ﹤0.01% |
44,549
-34,194
| -43% | -$134K |
|
8154
PUT
Blue Owl Capital
OBDC
$5.74B
| $180K | ﹤0.01% |
11,700
-8,500
| -42% | -$128K |
|
8155
CALL
Opko Health
OPK
$1.03B
| $179K | ﹤0.01% |
+149,100
| New | +$149K |
|
8156
PUT
Shoals Technologies Group
SHLS
$1.48B
| $179K | ﹤0.01% |
16,000
-11,200
| -41% | -$154K |
|
8157
SandRidge Energy
SD
$527M
| $178K | ﹤0.01% |
12,242
-19,617
| -62% | -$265K |
|
|
SCPH
8158
DELISTED
scPharmaceuticals
SCPH
| $178K | ﹤0.01% |
35,457
+11,575
| +48% | +$64.8K |
|
8159
Direct Digital Holdings
DRCT
$1.97M
| $178K | ﹤0.01% |
+53
| New | +$204K |
|
8160
GraniteShares 2x Long AAPL Daily ETF
AAPB
$16.4M
| $178K | ﹤0.01% |
+10,147
| New | +$205K |
|
8161
PUT
Payoneer
PAYO
$2.41B
| $177K | ﹤0.01% |
36,500
+22,400
| +159% | +$109K |
|
8162
PUT
BlackBerry
BB
$5.36B
| $177K | ﹤0.01% |
64,100
-148,600
| -70% | -$434K |
|
8163
GDS Holdings
GDS
$6.51B
| $177K | ﹤0.01% |
26,598
-48,603
| -65% | -$329K |
|
8164
Bain Capital Specialty
BCSF
$845M
| $177K | ﹤0.01% |
11,267
-32,079
| -74% | -$496K |
|
8165
PUT
Sally Beauty Holdings
SBH
$1.6B
| $176K | ﹤0.01% |
+14,200
| New | +$178K |
|
|
VXRT
8166
DELISTED
Vaxart
VXRT
| $176K | ﹤0.01% |
135,595
+114,073
| +530% | +$120K |
|
8167
PUT
Immatics
IMTX
$1.32B
| $176K | ﹤0.01% |
16,700
| – | – |
|
8168
Bionano Genomics
BNGO
$13M
| $175K | ﹤0.01% |
2,630
+1,486
| +130% | +$111K |
|
8169
CALL
Frontier Group Holdings
ULCC
$1.6B
| $175K | ﹤0.01% |
21,600
-100
| -0.5% | -$647 |
|
|
BFIN
8170
DELISTED
BankFinancial
BFIN
| $175K | ﹤0.01% |
+16,627
| New | +$171K |
|
|
HONE
8171
DELISTED
HarborOne Bancorp
HONE
| $175K | ﹤0.01% |
16,372
-6,201
| -27% | -$66.8K |
|
8172
LanzaTech
LNZA
$69.4M
| $174K | ﹤0.01% |
563
+263
| +88% | +$97.7K |
|
8173
Fennec Pharmaceuticals
FENC
$413M
| $173K | ﹤0.01% |
+15,554
| New | +$156K |
|
|
DESP
8174
CALL
DELISTED
Despegar.com
DESP
| $172K | ﹤0.01% |
+14,400
| New | +$136K |
|
8175
CALL
AbCellera Biologics
ABCL
$3.12B
| $172K | ﹤0.01% |
37,900
-117,700
| -76% | -$601K |
|
Similar funds
Jane Street's Q1 2024 Portfolio in Review
As of Q1 2024, Jane Street held 10,498 positions worth $478B, up 25% from $384B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Jane Street deployed $55.3B of net new capital in Q1 2024, opening 1,391 new positions and adding to 3,225 existing holdings. Its largest new stake was iShares MSCI EAFE Value ETF: 9,907,136 shares worth $539M.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 4.4% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.37B trimmed.
- Jane Street's largest Q1 2024 buy was iShares MSCI EAFE Value ETF: 9,907,136 shares worth $539M.
- Jane Street added most to iShares MSCI ACWI ETF in Q1 2024, an estimated $825M increase.
- Jane Street's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.37B.
- Jane Street fully exited JPMorgan Ultra-Short Income ETF in Q1 2024, selling an estimated $302M.
- Jane Street's ten largest holdings make up 51% of its $478B portfolio in Q1 2024.
- Jane Street opened 1,391 new positions and closed 1,402 in Q1 2024.
- Jane Street's portfolio value rose 25% quarter-over-quarter to $478B.
Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.